Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series. 2013

Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
Department of Medicinal Chemistry, AstraZeneca India Pvt Ltd, Avishkar, Bellary Road, Hebbal, Bangalore 560024, India. sreekanth.ramachandran@astrazeneca.com

Imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead were generated by whole cell screening of a focused library against Mycobacterium tuberculosis. Herein, we describe the synthesis and structure activity relationship evaluation of this class of inhibitors and the optimization of physicochemical properties. These are selective inhibitors of Mycobacterium tuberculosis with no activity on either gram positive or gram negative pathogens.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
December 2015, Molecules (Basel, Switzerland),
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
September 2017, European journal of medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
April 2009, European journal of medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
January 2007, Journal of combinatorial chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
December 2020, Bioorganic & medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
October 2009, European journal of medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
September 2017, Journal of medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
July 2016, Bioorganic & medicinal chemistry letters,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
September 2019, European journal of medicinal chemistry,
Sreekanth Ramachandran, and Manoranjan Panda, and Kakoli Mukherjee, and Nilanjana Roy Choudhury, and Subramanyam J Tantry, and Chaitanya Kumar Kedari, and Vasanthi Ramachandran, and Sreevalli Sharma, and V K Ramya, and Supreeth Guptha, and Vasan K Sambandamurthy
September 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!